Business
LifeStance Reports First Quarter 2025 Results
SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental
About this update from Lifestance Health Group, Inc.
[{"type":"text","content":"SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025. (All results compared to prior-year comparative period, unless otherwise noted)Q1 2025 Highlights and FY 2025 Outlook Revenue of $333.0 million increased 11% compared to revenue of $300.4 millionClinician base increased 10% to 7,535 clinicians, a sequential net increase of 152 in the first quarterFirst quarter visit volumes increased 10% to 2.1 millionNet income of $0.7 million compared to net loss of $21.1 millionNet cash used in operations of $3.1 million in the first quarterAdjusted EBITDA of $34.6 million compared to Adjusted EBITDA of $27.7 millionFree Cash Flow of negative $10.3 million in the first quarterFor full year 2025, reiterating expectations for revenue of $1.40 billion to $1.44 billion, Center Margin of $440 million to $464 million, and Adjusted EBITDA of $130 million to $150 million “We delivered a solid quarter to kick off 2025, thanks to the commitment and dedication of our employees, including over 7,500 clinicians,” said Dave Bourdon, CEO of LifeStance. “We exceeded our financial expectations with double-digit margins as well as positive net income in the quarter for the first time in our history as a public company. We look forward to continuing to enhance the patient and clinician experience at LifeStance while delivering on our mission of expanding access to mental healthcare services.” Financial Highlights Q1 2025 Q1 2024 Y/Y (in millions) Total revenue $333.0 $300.4 11%Income (loss) from operations 1.6 (16.8) (110%)Center Margin 109.8 94.7 16%Net income (loss) 0.7 (21.1) (103%)Adjusted EBITDA 34.6 27.7 25%As % of Total revenue: Income (loss) from operations 0.5% (5.6%) Center Margin 33.0% 31.5% Net income (loss) 0.2% (7.0%) Adjusted EBITDA 10.4% 9.2% (All results compared to prior-year period, unless otherwise noted) Revenue grew 11% to $333.0 million. Revenue growth in the first quarter was driven primarily by higher visit volumes from net clinician growth and improvements in total revenue per visit.Income from operations was $1.6 million and net income was $0.7 million.Center Margin grew 16% to $109.8 million, or 33.0% of total revenue.Adjusted EBITDA increas...